Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modafinil to Improve Fatiguability (MODIFY): Modafinil vs. Placebo Vanguard RCT

NCT05333250 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT05333250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05333250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modafinil to Improve Fatiguability (MODIFY): Modafinil vs. Placebo Vanguard RCT
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 16, 2026
Completion date
March 31, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-related cognitive difficulties, cancer-related problem/condition, fatigue